WASHINGTON - A panel of independent advisers to the U.S. Food and Drug Administration unanimously voted to endorse lower-dose booster shots of Moderna’s COVID-19 vaccine for seniors and other high-risk groups.The panel convened this week to review data and vote on whether the millions of Americans who received the Moderna or Johnson & Johnson COVID-19 vaccine should get a booster shot.
On Friday, the panel will hear evidence for the J&J booster shot and will also look into the safety and effectiveness of mixing and matching different brands of vaccines — something regulators have not endorsed so far.U.S.